Movement Alert｜Oscar Health, Inc. Rises 5.07% in Regular Trading, Buoyed by Analyst Price Target Upgrades and Strong Q2 Earnings Momentum

Market Focus

Yesterday

On September 15, Oscar Health, Inc. rose 5.07% in regular trading, trading at $34.43 per share, with turnover of $108 million.

On the catalyst front, Bank of America recently raised its price target on the stock from $25 to $28, with the average analyst consensus target standing at $31.09. The upward revision follows a blowout Q2 earnings report, in which the company posted EPS of $1.10, more than doubling the consensus estimate of approximately $0.42. Revenue reached $4.88 billion, beating the $4.75 billion estimate and surging over 70% year-over-year. Total effectuated membership climbed 46% year-over-year to approximately 2.96 million. The company reaffirmed full-year revenue guidance of $18.7 billion to $19.0 billion, above consensus. Multiple firms have raised targets in recent months, including Barclays upgrading to Overweight with a $35 target and UBS lifting its target from $20 to $26.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/news/1185134109"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1185134109\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1185134109?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-15 02:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1185134109","market":"us","top_or_hot":-1,"title":"Movement Alert｜Oscar Health, Inc. Rises 5.07% in Regular Trading, Buoyed by Analyst Price Target Upgrades and Strong Q2 Earnings Momentum","media":"Market Focus","content":"<p><p>On September 15, Oscar Health, Inc. rose 5.07% in regular trading, trading at $34.43 per share, with turnover of $108 million.</p><p>On the catalyst front, Bank of America recently raised its price target on the stock from $25 to $28, with the average analyst consensus target standing at $31.09. The upward revision follows a blowout Q2 earnings report, in which the company posted EPS of $1.10, more than doubling the consensus estimate of approximately $0.42. Revenue reached $4.88 billion, beating the $4.75 billion estimate and surging over 70% year-over-year. Total effectuated membership climbed 46% year-over-year to approximately 2.96 million. The company reaffirmed full-year revenue guidance of $18.7 billion to $19.0 billion, above consensus. Multiple firms have raised targets in recent months, including Barclays upgrading to Overweight with a $35 target and UBS lifting its target from $20 to $26.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Oscar Health, Inc. Rises 5.07% in Regular Trading, Buoyed by Analyst Price Target Upgrades and Strong Q2 Earnings Momentum</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Oscar Health, Inc. Rises 5.07% in Regular Trading, Buoyed by Analyst Price Target Upgrades and Strong Q2 Earnings Momentum\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-09-15 02:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On September 15, Oscar Health, Inc. rose 5.07% in regular trading, trading at $34.43 per share, with turnover of $108 million.</p><p>On the catalyst front, Bank of America recently raised its price target on the stock from $25 to $28, with the average analyst consensus target standing at $31.09. The upward revision follows a blowout Q2 earnings report, in which the company posted EPS of $1.10, more than doubling the consensus estimate of approximately $0.42. Revenue reached $4.88 billion, beating the $4.75 billion estimate and surging over 70% year-over-year. Total effectuated membership climbed 46% year-over-year to approximately 2.96 million. The company reaffirmed full-year revenue guidance of $18.7 billion to $19.0 billion, above consensus. Multiple firms have raised targets in recent months, including Barclays upgrading to Overweight with a $35 target and UBS lifting its target from $20 to $26.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OSCR","symbol_name":"Oscar Health, Inc.","start_time":0,"source_url":"","article_id":"1185134109","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1185134109","pubTimestamp":1789412305,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On September 15, Oscar Health, Inc. rose 5.07% in regular trading, trading at $34.43 per share, with turnover of $108 million.On the catalyst front, Bank of America recently raised its price target...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OSCR":"Oscar Health, Inc."},"translate_title":"走势警报|Oscar Health, Inc. 在分析师目标价上调和第二季度强劲盈利势头的推动下，常规交易中上涨 5.07%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OSCR":1},"content_text":"On September 15, Oscar Health, Inc. rose 5.07% in regular trading, trading at $34.43 per share, with turnover of $108 million.On the catalyst front, Bank of America recently raised its price target on the stock from $25 to $28, with the average analyst consensus target standing at $31.09. The upward revision follows a blowout Q2 earnings report, in which the company posted EPS of $1.10, more than doubling the consensus estimate of approximately $0.42. Revenue reached $4.88 billion, beating the $4.75 billion estimate and surging over 70% year-over-year. Total effectuated membership climbed 46% year-over-year to approximately 2.96 million. The company reaffirmed full-year revenue guidance of $18.7 billion to $19.0 billion, above consensus. Multiple firms have raised targets in recent months, including Barclays upgrading to Overweight with a $35 target and UBS lifting its target from $20 to $26.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}